CCR8 and neoplasm: Unlike other chemokines, such as CCR4, which is broadly expressed on Tregs in both tumoral and peripheral tissues [150], CCR8 expression appears to be largely restricted to tumor-infiltrating Tregs, potentially making it a safer immunotherapeutic target.